These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 26520

  • 1. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
    Furberg B, Dahlqvist A, Raak A, Wrege U.
    Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
    [Abstract] [Full Text] [Related]

  • 2. Angina pectoris: effective therapy once daily.
    Prager G.
    J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
    [Abstract] [Full Text] [Related]

  • 3. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA, Crawford MH, O'Rourke RA.
    Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
    [Abstract] [Full Text] [Related]

  • 4. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH, Heiman M, Soberman J, Greenberg S, Eff J.
    Am J Cardiol; 1991 Apr 01; 67(8):665-70. PubMed ID: 1672481
    [Abstract] [Full Text] [Related]

  • 5. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
    Jones GR, Mir MA.
    Br Heart J; 1981 Nov 01; 46(5):503-7. PubMed ID: 6119104
    [Abstract] [Full Text] [Related]

  • 6. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF, Grytter C, Thomsen S, Sigurd B.
    Clin Exp Pharmacol Physiol Suppl; 1982 Nov 01; 6():31-41. PubMed ID: 6126287
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH, Klein NA, Klein P, Strom JA, Tawil R, Strair R, Wong B, Roth S, LeJemtel TH, Pollack S, Sonnenblick EH.
    Am J Cardiol; 1982 Nov 01; 50(5):1164-72. PubMed ID: 6127946
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
    Nikolenko SA, Metelitsa VI, Nazarenko VA, Martsevich SIu, Kulikova TV.
    Kardiologiia; 1984 Feb 01; 24(2):14-8. PubMed ID: 6143849
    [Abstract] [Full Text] [Related]

  • 10. Improved physical performance as a therapeutic objective in patients with angina.
    Ling AS, Groel JT.
    Br J Clin Pharmacol; 1979 Feb 01; 7 Suppl 2(Suppl 2):161S-166S. PubMed ID: 37870
    [Abstract] [Full Text] [Related]

  • 11. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
    Subramanian VB, Bowles MJ, Davies AB, Raftery EB.
    Am J Cardiol; 1982 Nov 01; 50(5):1158-63. PubMed ID: 6127945
    [Abstract] [Full Text] [Related]

  • 12. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
    Shapiro W, Park J, DiBianco R, Singh SN, Katz RJ, Fletcher R.
    Chest; 1981 Oct 01; 80(4):425-30. PubMed ID: 6791883
    [Abstract] [Full Text] [Related]

  • 13. Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise.
    Higginbotham MB, Morris KG, Coleman RE, Cobb FR.
    Am J Cardiol; 1986 May 01; 57(13):1022-8. PubMed ID: 3085464
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of beta adrenergic blockade in coronary heart disease: propranolol in angina pectoris.
    Miller RR, Olson HG, Pratt CM, Amsterdam EZ, Mason DT.
    Clin Pharmacol Ther; 1975 Nov 01; 18(5 Pt 1):598-605. PubMed ID: 810295
    [Abstract] [Full Text] [Related]

  • 15. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM, Shaker A, Ramadan M, Hamza S, Tadros SS.
    J Int Med Res; 1980 Nov 01; 8(3):193-8. PubMed ID: 6104614
    [Abstract] [Full Text] [Related]

  • 16. Dose response effectiveness of propranolol for the treatment of angina pectoris.
    Alderman EL, Davies RO, Crowley JJ, Lopes MG, Brooker JZ, Friedman JP, Graham AF, Matlof HJ, Harrison DC.
    Circulation; 1975 Jun 01; 51(6):964-75. PubMed ID: 805675
    [Abstract] [Full Text] [Related]

  • 17. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W, Mitrovic V, Neuss H, Schlepper M, Cocco G, Prager G, Fitscha P, Meisner W.
    J Cardiovasc Pharmacol; 1991 Jun 01; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
    Hansteen V, Endresen K, Hellemann H, Eriksen II, Brorssen O, Ekeli T, Day M, Baber NS.
    Br J Clin Pharmacol; 1984 May 01; 17(5):579-84. PubMed ID: 6203546
    [Abstract] [Full Text] [Related]

  • 20. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
    BLoem TJ, Lindner PC.
    Ann Clin Res; 1981 May 01; 13 Suppl 30():61-7. PubMed ID: 6794420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.